You are here
Clinical Trials: Kidney Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Renal Cirrhosis
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Conditions: Chronic Kidney Diseases; Diabetes Mellitus; Diabetic Nephropathies
Interventions: Dietary Supplement: Fisetin; Drug: Placebo oral capsule
Sponsor: Mayo Clinic
Recruiting
Interventions: Dietary Supplement: Fisetin; Drug: Placebo oral capsule
Sponsor: Mayo Clinic
Recruiting
Conditions: Mesenchymal Stem Cells; Chronic Kidney Diseases; Renal Interstitial Fibrosis
Interventions: Drug: Treatment group; Drug: Control group
Sponsor: The Affiliated Hospital of Xuzhou Medical University
Recruiting
Interventions: Drug: Treatment group; Drug: Control group
Sponsor: The Affiliated Hospital of Xuzhou Medical University
Recruiting
Condition: Diabetic Nephropathies
Intervention: Biological: Wharton Jelly Mesenchymal stem cells
Sponsors: Sophia Al-Adwan; Jordan University of Science and Technology; An-Najah National University
Not yet recruiting - verified September 2017
Intervention: Biological: Wharton Jelly Mesenchymal stem cells
Sponsors: Sophia Al-Adwan; Jordan University of Science and Technology; An-Najah National University
Not yet recruiting - verified September 2017
Conditions: Renal Failure; End Stage Renal Disease; Hemodialysis; Vascular Access
Interventions: Biological: Human Acellular Vessel (HAV); Procedure: Arteriovenous fistula (AVF)
Sponsors: Humacyte, Inc.; CTI Clinical Trial and Consulting Services; California Institute for Regenerative Medicine (CIRM)
Recruiting
Interventions: Biological: Human Acellular Vessel (HAV); Procedure: Arteriovenous fistula (AVF)
Sponsors: Humacyte, Inc.; CTI Clinical Trial and Consulting Services; California Institute for Regenerative Medicine (CIRM)
Recruiting
Condition: Acute Kidney Injury
Interventions: Biological: SBI-101; Device: Sham
Sponsor: Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Interventions: Biological: SBI-101; Device: Sham
Sponsor: Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Condition: Moderate to Severe Chronic Kidney Disease
Intervention: Drug: Elixcyte
Sponsors: UnicoCell Biomed CO. LTD; A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016
Intervention: Drug: Elixcyte
Sponsors: UnicoCell Biomed CO. LTD; A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016
Conditions: Type 2 Diabetes Mellitus; Chronic Kidney Disease
Interventions: Drug: Canagliflozin; Drug: Placebo
Sponsors: George Washington University; Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Interventions: Drug: Canagliflozin; Drug: Placebo
Sponsors: George Washington University; Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Intervention: Biological: Extra blood draw samples
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Conditions: End Stage Renal Disease (ESRD); Vascular Access Complication
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor: Mayo Clinic
Not yet recruiting - verified June 2016
Intervention: Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor: Mayo Clinic
Not yet recruiting - verified June 2016
